NJ
Nupur Jain
About Nupur Jain
Data last updated:
Nupur Jain is a Designated Partner at Molecular Diagnostics And Therapy Llp (since 2025). The company operates in Healthcare. Molecular Diagnostics And Therapy Llp reported revenue of ₹26.49 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 12 Sep 2025 | 2017 | ₹26.49 Cr (FY 2023) | Active |
Board colleagues of Nupur Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aviral Gupta | 10759625 | Molecular Diagnostics And Therapy Llp | Designated Partner |
| Mohit Gupta | 06792699 | Molecular Diagnostics And Therapy Llp | Partner |
| Nidhi Gupta | 06793869 | Molecular Diagnostics And Therapy Llp | Designated Partner |
| Nikunj Jain | 07985374 | Molecular Diagnostics And Therapy Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nupur Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nupur Jain
Nupur Jain currently holds 1 directorship: Molecular Diagnostics And Therapy Llp (Designated Partner, since 12 Sep 2025, revenue ₹26.49 Cr (FY 2023)).
Nupur Jain was first appointed on 12 Sep 2025 as Designated Partner at Molecular Diagnostics And Therapy Llp.
The current boards of Nupur Jain's companies include Aviral Gupta (Molecular Diagnostics And Therapy Llp), Mohit Gupta (Molecular Diagnostics And Therapy Llp), Nidhi Gupta (Molecular Diagnostics And Therapy Llp), Nikunj Jain (Molecular Diagnostics And Therapy Llp).